Pfizer/BioNTech seeks EU jab approval for ages 12-15
HEALTH

Pfizer/BioNTech seeks EU jab approval for ages 12-15

Pfizer/BioNTech seeks EU jab approval for ages 12-15

File photo

-/-

Vaccine shows 100% efficacy in participants aged 12-15 years in Phase 3 trials, say pharma firms

  • News Service 01 MAY 2021, 10:11AA
  • Pfizer
  • BioNTech
  • approval
SON DAKİKA

#title#